Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild to Moderate Alzheimer's Disease”

Showing 20 of 0 results

Not applicableStudy completedNCT02007291
What this trial is testing

Good Rate of Clinical Response to Cholinesterase Inhibitors in Alzheimer's Disease After Three Months of Treatment

Who this might be right for
Late Onset Alzheimer
Federal University of Minas Gerais 71
Testing effectiveness (Phase 2)Study completedNCT00663026
What this trial is testing

Study Evaluating Bapineuzumab In Alzheimer Disease Subjects

Who this might be right for
Alzheimer Disease
Pfizer 79
Large-scale testing (Phase 3)Study completedNCT02293915
What this trial is testing

An Efficacy and Safety Study of Sodium Oligo-mannurarate (GV-971) Capsule for the Treatment of Alzheimer's Disease

Who this might be right for
Mild to Moderate Alzheimer DiseaseCognitive Impairment
Shanghai Greenvalley Pharmaceutical Co., Ltd. 818
Large-scale testing (Phase 3)Study completedNCT00428090
What this trial is testing

Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline 862
Testing effectiveness (Phase 2)Study completedNCT03069014
What this trial is testing

Study of LM11A-31-BHS in Mild-moderate AD Patients

Who this might be right for
Mild to Moderate Alzheimer's Disease
PharmatrophiX Inc. 242
Large-scale testing (Phase 3)Ended earlyNCT00676143
What this trial is testing

Study Evaluating the Safety and Efficacy of Bapineuzumab in Alzheimer Disease Patients

Who this might be right for
Alzheimer Disease
Pfizer 1,100
Early research (Phase 1)Study completedNCT00495417
What this trial is testing

Tolerability and Safety of Subcutaneous Administration of Affitope AD01 in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Affiris AG 24
Testing effectiveness (Phase 2)Study completedNCT00710684
What this trial is testing

SB-742457, Added to Donepezil for the Treatment of Mild-to-moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline 682
Not applicableStudy completedNCT01478204
What this trial is testing

Evaluate Sleep Quality in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Janssen-Cilag, S.A. 925
Very early researchStudy completedNCT03577262
What this trial is testing

A Non-therapeutic Feasibility Study of the Radioligand [11C]-UCB-J for Imaging Synaptic Density

Who this might be right for
HealthyAlzheimer Disease
Alkermes, Inc. 19
Testing effectiveness (Phase 2)Study completedNCT03055741
What this trial is testing

Study of DHP1401 in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil(DRAMA)

Who this might be right for
Mild-moderate Alzheimer's Disease
Daehwa Pharmaceutical Co., Ltd. 180
Testing effectiveness (Phase 2)Study completedNCT00945672
What this trial is testing

A Multiple Dose Study of PF-04360365 In Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 36
Testing effectiveness (Phase 2)Study completedNCT03625622
What this trial is testing

Efficacy and Safety of 26-Week Treatment of AR1001 in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Mild to Moderate Alzheimer's Disease
AriBio Co., Ltd. 210
Testing effectiveness (Phase 2)Study completedNCT00285077
What this trial is testing

Long-Term Safety Extension With SR57667B in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Sanofi 390
Large-scale testing (Phase 3)UnknownNCT03283059
What this trial is testing

Octohydroaminoacridine Succinate Tablet for Mild-to-Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Shanghai Mental Health Center 600
Testing effectiveness (Phase 2)Study completedNCT00708552
What this trial is testing

Study of SB-742457 or Donepezil Versus Placebo in Subjects With Mild-to-moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline 576
Not applicableUnknownNCT04260724
What this trial is testing

Study on the Effect of Transcranial Magnetic Stimulation in Mild to Moderate Alzheimer's Disease

Who this might be right for
Mild to Moderate Alzheimer Disease
Samsung Medical Center 32
Testing effectiveness (Phase 2)Study completedNCT00742417
What this trial is testing

Efficacy and Safety of Plasma Exchange With 5% Albumin in Beta-amyloid Peptide Clearance in Cerebral Spinal Fluid

Who this might be right for
Alzheimer's Disease
Instituto Grifols, S.A. 42
Very early researchStudy completedNCT01024660
What this trial is testing

The Effect of Cognitive Function as Measured by Repeated Cognitive Measures After 12 Weeks Treatment With Donepezil

Who this might be right for
Alzheimer's Disease
AstraZeneca 155
Early research (Phase 1)Study completedNCT00733642
What this trial is testing

Single Dose Escalation Study of PF-04360365 In Subjects With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 15
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation